JP2013523814A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523814A5
JP2013523814A5 JP2013503806A JP2013503806A JP2013523814A5 JP 2013523814 A5 JP2013523814 A5 JP 2013523814A5 JP 2013503806 A JP2013503806 A JP 2013503806A JP 2013503806 A JP2013503806 A JP 2013503806A JP 2013523814 A5 JP2013523814 A5 JP 2013523814A5
Authority
JP
Japan
Prior art keywords
alkyl
halo
substituted
mono
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013503806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013523814A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/031040 external-priority patent/WO2011126960A1/en
Publication of JP2013523814A publication Critical patent/JP2013523814A/ja
Publication of JP2013523814A5 publication Critical patent/JP2013523814A5/ja
Pending legal-status Critical Current

Links

JP2013503806A 2010-04-08 2011-04-04 Faahの調節薬として有用なオキサゾール誘導体 Pending JP2013523814A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32199210P 2010-04-08 2010-04-08
US61/321,992 2010-04-08
PCT/US2011/031040 WO2011126960A1 (en) 2010-04-08 2011-04-04 Oxazole derivatives useful as modulators of faah

Publications (2)

Publication Number Publication Date
JP2013523814A JP2013523814A (ja) 2013-06-17
JP2013523814A5 true JP2013523814A5 (enExample) 2014-05-22

Family

ID=44763231

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013503806A Pending JP2013523814A (ja) 2010-04-08 2011-04-04 Faahの調節薬として有用なオキサゾール誘導体

Country Status (8)

Country Link
US (1) US9193697B2 (enExample)
EP (1) EP2555772B1 (enExample)
JP (1) JP2013523814A (enExample)
CN (1) CN102917704A (enExample)
AU (1) AU2011238487B2 (enExample)
BR (1) BR112012023974A2 (enExample)
CA (1) CA2793900A1 (enExample)
WO (1) WO2011126960A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102171196B (zh) * 2008-08-04 2015-03-25 默沙东公司 用作脂肪酸酰胺水解酶的抑制剂的*唑衍生物
US9006433B2 (en) 2010-04-21 2015-04-14 Merck Sharp & Dohme Corp. Substituted pyrimidines
EP3580218A1 (en) 2017-02-08 2019-12-18 Bayer CropScience Aktiengesellschaft Novel triazole derivatives
BR112019016241A2 (pt) 2017-02-08 2020-04-07 Bayer Cropscience Ag derivados de triazol e seu uso como fungicidas
CA3052519A1 (en) 2017-02-08 2018-08-16 Andreas Gortz Triazolethione derivatives
AU2018217749A1 (en) 2017-02-10 2019-08-01 Bayer Aktiengesellschaft Composition for controlling harmful microorganisms comprising 1 -(phenoxy-pyridinyl)-2-(1,2,4-triazol-1 -yl)-ethanol derivatives
CA3066423A1 (en) * 2017-06-14 2018-12-20 Trevena, Inc. Compounds for modulating s1p1 activity and methods of using the same
WO2020020816A1 (en) 2018-07-26 2020-01-30 Bayer Aktiengesellschaft Novel triazole derivatives
CN110804048A (zh) * 2019-11-08 2020-02-18 暨南大学 恶唑酮类化合物及其应用、faah的正电子药物
MX2022005766A (es) 2019-11-19 2022-08-08 Trevena Inc Compuestos y métodos para la preparación de compuestos moduladores de esfingosina 1-fosfato tipo 1 (s1p1).
KR102955312B1 (ko) * 2023-08-29 2026-04-21 인천대학교 산학협력단 옥사졸 유사체를 유효성분으로 포함하는 항노화 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2023728A4 (en) 2006-05-26 2010-11-24 Janssen Pharmaceutica Nv OXAZOLYLPIPERIDINES AS MODULATORS OF FATTY ACID AMIDHYDROLASE
FR2921063B1 (fr) * 2007-09-13 2009-12-11 Sod Conseils Rech Applic Ligands des recepteurs cannabinoides
JP2011523959A (ja) * 2008-06-11 2011-08-25 メルク・シャープ・エンド・ドーム・コーポレイション Faahの阻害剤として有用なイミダゾール誘導体
CN102171196B (zh) * 2008-08-04 2015-03-25 默沙东公司 用作脂肪酸酰胺水解酶的抑制剂的*唑衍生物
US20130030000A1 (en) * 2010-01-28 2013-01-31 Chobanian Harry R Pharmaceutical compositions for the treatment of pain and other indications

Similar Documents

Publication Publication Date Title
JP2013525356A5 (enExample)
AU2018358160B2 (en) Modulators of the integrated stress pathway
JP2016516043A5 (enExample)
KR20190041471A (ko) 케모카인 수용체 조절제 및 이의 용도
SI3018132T1 (en) Condensed imidazole derivatives useful as IDO inhibitors
JP2016525076A5 (enExample)
ES2910071T3 (es) Compuestos de aminopirazina diol como inhibidores de PI3K-Y
JP2015524472A5 (enExample)
JP6529492B2 (ja) 癌の処置のためのidh2突然変異体阻害剤としての2,4−または4,6−ジアミノピリミジン化合物
JP2019533694A5 (enExample)
JP2013528204A5 (enExample)
US20200361881A1 (en) Modulators of the integrated stress pathway
JP2014528464A5 (enExample)
JP2015535277A5 (enExample)
EA032609B1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
JP2011500806A5 (enExample)
JP2016522232A5 (enExample)
EA028122B1 (ru) 3-пиримидин-4-илоксазолидин-2-оны в качестве ингибиторов мутантного idh
PH12014501561B1 (en) Therapeutically active compounds and their methods of use
JP2016525075A5 (enExample)
RU2017118165A (ru) Ингибиторы энхансера гомолога 2 zestes
RU2015101102A (ru) Гетероароматическое метильное производное циклического амина
JP2014510147A5 (enExample)
JP2016513696A5 (enExample)
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета